IPO - IceCure Medical Ltd.

Form Type: 424B5

Filing Date: 2025-01-13

Corporate Action: Ipo

Type: New

Accession Number: 000121390025002851

Filing Summary: IceCure Medical Ltd. has entered into an equity distribution agreement with Maxim Group LLC on January 13, 2025, for the sale of ordinary shares valued at up to $13,960,500. The agreement allows IceCure to conduct sales through an 'at the market offering' as described in Rule 415 of the Securities Act of 1933. The Sales Agent will earn a commission of 2.5% of the gross sales price per share sold. As of January 10, 2025, IceCure had 56,568,999 ordinary shares outstanding and intends to use the proceeds for research, development, marketing, and general corporate purposes. The company also notes significant risks related to investing due to the regional instability in Israel, including the ongoing conflict with Hamas, which may impact its operations and business continuity.

Document Link: View Document